Midgard

Genoskin

Salem, MA, United States genoskin.com From their website, Nov 2026

  • ISO 9001

Work here? Claim this listing

About

Genoskin provides ex vivo human skin models, human primary mast cells, and custom non-clinical studies for drug, vaccine, medical device, cosmetic, and academic research. The company operates in France and the United States and serves customers worldwide.

Services

  • Injection Site Toxicology

    Assesses local toxicity and inflammatory responses after injection in ex vivo human skin.

    ADME, DMPK & toxicology

  • Injection Site Reaction Testing

    Evaluates local immune activation and tissue response to injectable therapeutics in ex vivo human skin.

    ADME, DMPK & toxicology

  • Local Tolerance Studies

    Tests cytotoxicity and local tolerance at contact sites using ex vivo human skin models.

    ADME, DMPK & toxicology

  • Toxicity Pilot Study

    Runs a 5-day feasibility study in living human skin to generate early local toxicity and immune response data for injectables.

    ADME, DMPK & toxicology

  • Inflammatory Skin Disease Research

    Supports studies in inflammatory skin disease using ex vivo human skin platforms.

  • Psoriasis Research

    Supports anti-psoriasis studies using human skin models.

  • Type-2 Barrier Impairment Research

    Supports research on barrier impairment using human skin platforms.

  • Hidradenitis Suppurativa Research

    Supports research on hidradenitis suppurativa using human skin models.

9 more services
  • Vaccine Development
  • Topical and Transdermal Evaluation
  • Human Mast Cells Services
  • Assays and Readouts
  • Spatial Biology Platform
  • Bioinformatic Analysis
  • Cosmetic Claim Substantiation
  • Barrier Function Studies
  • Topical Delivery
What to send
  • Donated human skin
  • Injectable therapeutic or vaccine
  • Healthy human skin for HypoSkin studies

Capabilities

Assays and studies
  • Toxicology
  • Antibodies
  • ADCs
  • Peptides
  • Histopathology
  • H&E staining
9 more
  • TUNEL assays
  • Multiplex cytokine analysis
  • Transcriptomics
  • Multiplexed proteomics
  • Bioinformatics
  • Gene expression signatures
  • Histology-based assessments
  • Secreted inflammatory mediators
  • Biomarker analysis
Scale and capacity
  • Up to 10 days in culture
  • 5-day ex vivo pilot study
  • One donor before multi-donor investigation
Therapeutic areas
  • Inflammatory skin disease
  • Psoriasis
  • Hidradenitis suppurativa
  • Type-2 barrier impairment
  • Vaccine development
  • Local toxicity
  • Immunotoxicity
  • Allergy

Instruments and platforms

  • Next-generation transcriptomics
  • Multiplexed proteomics

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • ADC
  • Peptide
  • mRNA
  • Cell therapy
  • Vaccine
Species and models
  • Donated human skin
  • Healthy human skin
  • HypoSkin
  • NativeSkin
  • WoundSkin
  • HairSkin
3 more
  • Human Mast Cells
  • Connective-tissue type human primary mast cells
  • Healthy donor mast cells

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO 9001Self-reported

    Scope: Genoskin SAS facility in France; human tissue sourcing, biobanking, skin model production, preclinical testing services,

  • GLPSelf-reported

Company

Type
CRO
Founded
2017
Ownership
Small business, as registered with SAM.gov or stated on their site

Locations

Based in
Salem, MA, United States
Sites
  • Toulouse, France
  • Salem, MA, United States
Serves
Worldwide, North America

Public records

Biocom California CRO directory
ex vivo human skin models, new approach methodologies, safety toxicology models, skin immunology, subcutaneous injection research source

Similar labs